Wu Capital

Nuvig Therapeutics focuses on developing innovative therapies aimed at restoring immune homeostasis and rebalancing immune function. The company is dedicated to creating a pipeline of novel immune therapeutics specifically targeting chronic inflammatory and autoimmune diseases. By harnessing natural mechanisms to modulate immune responses, Nuvig seeks to enhance treatment options for patients, ultimately improving their health outcomes.

Ray Therapeutics is a biotechnology company focused on developing innovative optogenetic gene therapies aimed at treating patients with blinding diseases. The company is dedicated to advancing technology that facilitates the understanding and study of rare retinal diseases. By harnessing optogenetics, Ray Therapeutics aims to empower medical professionals to effectively cure and manage inherited retinal disorders, thereby improving the quality of life for affected individuals.

Rona Therapeutics is an innovative RNA therapeutics platform focused on the discovery, development, and commercialization of modular and programmable RNA medicines. The company specializes in oligonucleotide therapies, RNA editing, and polymeric molecules, aiming to create transformative RNA therapies that can significantly impact disease treatment across various therapeutic areas. Rona Therapeutics is committed to developing proprietary technologies that enhance the specificity, stability, and longevity of therapeutic effects. To support its mission, the company is establishing state-of-the-art facilities to advance nucleic acid synthesis, delivery platforms, and RNA biology. Through its efforts, Rona Therapeutics seeks to improve patient health outcomes and foster an environment conducive to innovation and excellence in RNA medicine.

Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

RiVAI Technologies is a prominent developer of high-performance RISC-V based CPUs and customized system-on-chip (SoC) designs. The company specializes in creating advanced artificial intelligence chips tailored for Internet of Things (IoT) applications, serving a diverse range of sectors such as wearable technology, smart home devices, security systems, agriculture, and consumer electronics. By leveraging RISC-V, an open standard instruction set architecture, RiVAI enables its clients to achieve low-power and high-performance processing capabilities essential for modern computing demands, from edge devices to data centers.

Ranok Therapeutics is a biotechnology company specializing in the development of innovative targeted protein degradation technology to facilitate the discovery and development of new therapeutics. This technology engages various biological processes and aims to surpass existing methods in the field. Ranok's research pipeline includes both established and novel drug targets that address cancer and other diseases with considerable unmet medical needs. The company is committed to creating the next generation of cancer therapies that prioritize safety and effectiveness for patients facing serious health challenges.

FeiLiu Tech is a Shanghai-based clothing supply chain service company, established in 2016 by a team of scientists from IBM's Dr. Watson. As a national high-tech enterprise, it specializes in the application of artificial intelligence to optimize supply chain management within the garment industry. FeiLiu Tech connects various stakeholders, including fabric suppliers, garment factories, industrial workers, e-commerce platforms, and brand owners, to facilitate efficient and continuous supply chain services. The company's commitment to technological innovation aims to enhance operational efficiency and streamline processes in the clothing sector.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

Gemini Therapeutics, Inc. is a precision medicine company based in Cambridge, Massachusetts, founded in 2015. The company specializes in developing new therapies for patients experiencing dry age-related macular degeneration (AMD) and related rare genetic diseases. Gemini Therapeutics focuses on genetically defined conditions, creating therapeutic candidates that address molecular abnormalities in patients with significant clinical needs. Their diverse pipeline encompasses monoclonal antibodies, recombinant proteins, and gene therapies, positioning the company to potentially introduce first-in-class therapeutics. The development of these innovative treatment options is supported by collaborations with leading life science investors and academic institutions worldwide, reflecting a commitment to advancing medical care for individuals suffering from these conditions.

Medbanks Network Technology, based in Beijing and founded in 2014, specializes in data processing services tailored for the healthcare sector. The company focuses on developing an oncology database that consolidates clinical and professional medical services, leveraging information collected from hospitals. This initiative enhances the availability of critical data for healthcare providers and researchers. Medbanks plays a significant role in supporting the healthcare industry's need for accurate and comprehensive medical information, thereby contributing to advancements in patient care and treatment methodologies.

Inipharm Inc. is a biopharmaceutical company established in 2018 and headquartered in Bellevue, Washington. The company specializes in discovering and developing therapies for severe liver diseases. Its research focuses on small-molecule drugs that target HSD17B13, a gene implicated in various liver conditions, including nonalcoholic steatohepatitis (NASH). By modulating the activity of HSD17B13, Inipharm aims to provide innovative treatments that can significantly reduce liver damage, inflammation, and fibrosis in affected patients.

Deptrum Limited is a technology company that specializes in developing optical technology and 3D vision solutions, founded in 2018 by three scientists from Silicon Valley. Headquartered in Shanghai, with an additional location in Shenzhen, Deptrum offers a comprehensive full-stack solution that encompasses both hardware and software, enabling advanced 3D computer vision capabilities. The company's innovative technology leverages nanophotonics and data-driven algorithms, allowing it to deliver superior 3D visual solutions across various industries. Its products are utilized in applications such as intelligent terminals, artificial intelligence, virtual reality, intelligent security, robotics, and automated medical devices. Notably, Deptrum has created the world's first non-VCSEL structured light solution, which powers a range of AIoT devices, including mobile robots and augmented reality devices.

Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

Citrine Medicine is a rare disease-focused pharmaceutical firm.

Akouos, Inc. is a biotechnology company dedicated to developing precision genetic medicine aimed at restoring, improving, and preserving hearing for individuals with various forms of hearing loss. Utilizing a proprietary adeno-associated viral vector library and an innovative delivery approach, Akouos focuses on gene therapies tailored to genetically-defined patient populations, including those affected by specific genetic mutations, ototoxic drug exposure, and age-related hearing loss. The company's lead product candidate, AK-OTOF, targets hearing loss associated with mutations in the OTOF gene. Founded in 2016 and based in Boston, Massachusetts, Akouos collaborates with strategic partners, including Massachusetts Eye and Ear and Lonza, Inc., to advance its mission of providing effective treatments for sensorineural hearing loss.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

PACT Pharma, Inc. is a biotechnology company focused on developing personalized cell-based therapies for cancer treatment. The company specializes in neoantigen-specific adoptive T-cell therapies aimed at solid tumors. Its innovative platform utilizes bioinformatics to analyze patients' tumor and normal DNA and RNA, identifying candidate neoantigen peptides that stimulate robust antitumor T-cell responses. By pinpointing neo-epitopes unique to each patient's cancer, PACT Pharma enables the engineering of autologous T cells that specifically target and eradicate tumors expressing these neo-antigens. Founded in 2016 and headquartered in South San Francisco, California, PACT Pharma is dedicated to advancing personalized medicine in oncology.

Medbanks Network Technology, based in Beijing and founded in 2014, specializes in data processing services tailored for the healthcare sector. The company focuses on developing an oncology database that consolidates clinical and professional medical services, leveraging information collected from hospitals. This initiative enhances the availability of critical data for healthcare providers and researchers. Medbanks plays a significant role in supporting the healthcare industry's need for accurate and comprehensive medical information, thereby contributing to advancements in patient care and treatment methodologies.

Loving Care International Pet Hospital is a comprehensive animal medical institution that operates a chain of clinics and hospitals focused on pet healthcare services. The facility offers a range of services including beauty treatments, physical examinations, vaccinations, and clinics. In addition to standard medical care, Loving Care provides users with information on the prevention of common diseases in dogs and cats, as well as alternative pet health issues. The establishment also operates mobile animal service vehicles to deliver home-based basic medical services, ensuring that pets receive the care they need in a convenient manner. Through its commitment to improving the diagnosis and treatment of pet diseases, including serious conditions such as tumors, Loving Care aims to enhance the overall well-being of animals and support pet owners in maintaining their pets' health.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

Deptrum Limited is a technology company that specializes in developing optical technology and 3D vision solutions, founded in 2018 by three scientists from Silicon Valley. Headquartered in Shanghai, with an additional location in Shenzhen, Deptrum offers a comprehensive full-stack solution that encompasses both hardware and software, enabling advanced 3D computer vision capabilities. The company's innovative technology leverages nanophotonics and data-driven algorithms, allowing it to deliver superior 3D visual solutions across various industries. Its products are utilized in applications such as intelligent terminals, artificial intelligence, virtual reality, intelligent security, robotics, and automated medical devices. Notably, Deptrum has created the world's first non-VCSEL structured light solution, which powers a range of AIoT devices, including mobile robots and augmented reality devices.

Sanjieke is an online education platform focused on serving IT professionals in China. The company specializes in vocational education and corporate training, offering a diverse array of courses aimed at fostering professional growth. Through its online platform, Sanjieke provides industry-specific knowledge and skills that are often not available in traditional educational institutions. This approach enables students to acquire relevant expertise and adapt to the evolving demands of the job market.

Cassia Networks is a wireless telecommunications company specializing in Bluetooth technology, founded by Felix Zhao in 2014. With offices in Silicon Valley and Beijing, the company aims to enhance Bluetooth capabilities for local area networks, addressing the connectivity and management challenges of the Internet of Things (IoT). Cassia Networks offers a range of products, including the Cassia Hub Bluetooth router, which gained recognition as the world's first Bluetooth router at CES 2016. This innovative hub allows for long-distance control of up to 22 Bluetooth devices, moving beyond the traditional limitations of short-range device pairing. Additionally, the product portfolio includes smart plugs, multi-color LEDs, personal safety sensors, and Bluetooth speakers, all designed to facilitate reliable and efficient management of numerous IoT devices remotely.

Smart Bees is a developer of innovative foldable furniture designed to optimize small living spaces, primarily targeting consumers in China. The company focuses on creating stylish and functional pieces that blend fashion, simplicity, and sustainability. By prioritizing environmentally safe materials, Smart Bees aims to provide high-quality furniture solutions that meet the evolving needs of modern urban dwellers.

Cobo is a leading provider of digital asset custody solutions, founded in 2017 and headquartered in Singapore. The company specializes in creating secure and efficient management systems for digital assets, catering primarily to institutional clients. Cobo offers an omni-custody platform that includes a range of custody technologies, such as full custody utilizing bank-grade hardware security modules, co-managed custody based on advanced multi-party computation, and fully decentralized self-custody through smart contracts. Additionally, Cobo provides services like Wallet-as-a-Service and SuperLoop, an off-exchange settlement network. With over 500 institutional clients and billions of dollars in assets under custody, Cobo serves a diverse clientele that includes exchanges, investment funds, and traditional financial institutions across multiple regions. The company emphasizes security and regulatory compliance, holding SOC 2 certification and licenses in several jurisdictions, including the United States and Singapore. Cobo has garnered support from prominent global investors, further solidifying its position in the digital asset management space.

Meng Fan Japanese is an online education platform.

Newtop100.com is a media and entertainment company based in Beijing, China, founded in 2016. It specializes in publishing news reports and conducting interviews with leaders in the new economy, focusing on innovative technologies and emerging business models. Through various audio and digital media platforms, Newtop100.com provides in-depth coverage and analysis of over 100 leading companies, allowing clients to explore investment opportunities within this dynamic sector. The company aims to highlight pioneers in different domains of the new economy, facilitating informed decisions for investors and stakeholders alike.

Kangaroo Mama is a Shanghai-based company that offers professional child day care services for children up to three years old. Founded in 2016, it provides a range of services including infant care, evening care for children aged three to six, and temporary care during summer and winter vacations. Additionally, Kangaroo Mama supports primary school services, catering specifically to the needs of working parents in first-tier cities in China. The company's focus is on fostering the cognitive, awareness, language, and social skills of young children, ensuring that parents have access to reliable and beneficial daycare options.

Roadstar.AI is a startup based in Silicon Valley and Shenzhen, founded by experts in robotics and machine learning with backgrounds at prominent companies such as Google, Tesla, Nvidia, Apple, and Baidu. The company specializes in developing autonomous driving technology aimed at enhancing transportation safety, efficiency, and accessibility. Roadstar.AI employs a unique multi-sensor fusion framework that ensures accurate time and spatial synchronization, enabling real-time updates and robust feature extraction from high-dimensional raw data. This technology is designed to create a safer and more enjoyable travel experience for both cars and trucks, contributing to the evolution of advanced transportation systems.

Youyang Media is an education content sharing platform based in Beijing, China, that focuses on parental education for children up to twelve years of age. Founded in 2016, the company offers a variety of resources, including personalized childcare knowledge videos, offline activities, and educational products. Its platform features systematic original parenting videos as well as virtual and augmented reality content, particularly emphasizing ancient Chinese legends. Through these offerings, Youyang aims to support parents in enhancing their children's growth and development.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

Semma Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative cell therapies for patients with Type 1 diabetes. Founded in 2014, the company is dedicated to creating a transformative treatment that addresses the need for insulin injections by generating functional, insulin-producing beta cells through a proprietary method licensed from the laboratory of Professor Douglas Melton. Semma Therapeutics aims to combine these engineered cells with advanced devices to offer a potential replacement for the missing beta cells in diabetic patients, eliminating the need for immunosuppression. The company's ongoing research seeks to bring this novel therapeutic option to clinical settings, ultimately improving the lives of individuals living with diabetes.

Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.

Yunding Network Technology is a developer of smart home security systems, specializing in smart locks in the smart apartment segment under its brands Loock and Yunding.

Liulishuo is a leading artificial intelligence-driven educational technology company founded in September 2012 by Dr. Wang Wei and Dr. Hu Zhe and Dr. Lin Hui. Liulishuo offers a personalized and adaptive language learning experience to 50 million learners in 379 cities in China and over 175 countries around the world. Its self-developed artificial intelligence English teacher, based on deep learning technology, can provide personalized and adaptive learning courses for each user.

Namihe is a digital textbook and smart reading service platform that offers rich reading content and creates a range of reading settings for kids between the ages of 6 and 15. They provide a learning tool for the school students.

Cui Yutao Children Health Management Center is focused on the development of a comprehensive platform for children's physical and mental health management. The center provides an integrated mobile application that facilitates daily health tracking, online parenting community interactions, and access to expert guidance in pediatrics. This application also offers medical assistance and child health insurance services, designed to equip parents with essential resources and information for effective childcare. Through its online and offline services, Cui Yutao aims to enhance the overall well-being of children by offering up-to-date advice on medical care, early-stage education, and infant product recommendations.

Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.

Cui Yutao Children Health Management Center is focused on the development of a comprehensive platform for children's physical and mental health management. The center provides an integrated mobile application that facilitates daily health tracking, online parenting community interactions, and access to expert guidance in pediatrics. This application also offers medical assistance and child health insurance services, designed to equip parents with essential resources and information for effective childcare. Through its online and offline services, Cui Yutao aims to enhance the overall well-being of children by offering up-to-date advice on medical care, early-stage education, and infant product recommendations.

Apricot Forest is a provider of an online medical platform aimed at enhancing the practice of Chinese doctors through a mobile application. This app offers access to patient records, medical journals, and discussion boards, facilitating a more professional and intimate clinical experience. By integrating scientific resources with a focus on the humanities, Apricot Forest's platform seeks to improve efficiency and increase productivity for healthcare professionals. The company's mission is to simplify medical practice, enabling doctors to deliver better care to their patients.

XiaoHongChun is a prominent platform that caters to young women by combining a vertical short video community with a fashion business model. Launched in April 2015, the company operates various segments, including the Xiaohonglip app, internet celebrity brokerage, beauty brand operations, and cross-border e-commerce supply chain. By facilitating social interactions in the beauty and fashion sectors, XiaoHongChun effectively guides consumers through cosmetics video sharing and offers shopping assistance, thereby enhancing the shopping experience for its users.

Qianding is the development of smart cities and communities. They focus on intelligent solutions for communities, parks, businesses, apartments, and other spaces. They provide services like integrated service reconstruction. They offer smart community management, smart access control, and smart community solutions. They empower ecological integration to promote synergy and sustainable development.